Patients with GCA receiving combination IVMP/MTX with lower-dose prednisone had lower cumulative GC doses and fewer related side effects vs SOC.

GREEN BAY, Wis., Nov. 28, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Donald Massenburg, MD, Ph.D, FACP, FACR is recognized as a Pinnacle Lifetime Member for his contributions to ...

A new clinical study published in the Annals of the Rheumatic Diseases found that adding the investigational drug clofutriben ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...

A successful claim for PIP can now provide between £29.20 and £187.45 per week in additional financial support. Given that ...

The most recent DWP statistics also indicate that over 3.8 million people in England and Wales are now claiming PIP. A ...

Nearly 1.2 million UK adults receive support for health conditions, with payments ranging from £116.80 to £749.80 every four ...

About a year ago, a test revealed that I had an 8-mm stone in my kidney. My kidney doctor was not worried about it. I have ...

My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three ...

A dding an investigational drug called clofutriben to corticosteroid therapy could make the latter less toxic in long-term use, a pilot trial in patients with polymyalgia rheumatica (PMR) suggested.